![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Goodnick Paul J
Publisher: Informa Healthcare
ISSN: 1465-6566
Source: Expert Opinion on Pharmacotherapy, Vol.2, Iss.10, 2001-10, pp. : 1655-1662
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Drug safety evaluation of ziprasidone
Expert Opinion on Drug Safety, Vol. 10, Iss. 3, 2011-05 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Safety profile of the triptans
By Tepper Stewart J Millson David
Expert Opinion on Drug Safety, Vol. 2, Iss. 2, 2003-03 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Expert Opinion on Drug Safety, Vol. 4, Iss. 6, 2005-11 ,pp. :